Exploring Upward and Downward Provider Biases in Family Planning: The Case of Parity.


Journal

Global health, science and practice
ISSN: 2169-575X
Titre abrégé: Glob Health Sci Pract
Pays: United States
ID NLM: 101624414

Informations de publication

Date de publication:
21 Jun 2023
Historique:
received: 23 01 2023
accepted: 24 05 2023
medline: 26 6 2023
pubmed: 23 6 2023
entrez: 22 6 2023
Statut: epublish

Résumé

Provider bias has become an important topic of family planning research over the past several decades. Much existing research on provider bias has focused on the ways providers restrict access to contraception. Here, we propose a distinction between the classical "downward" provider bias that discourages contraceptive use and a new conception of "upward" provider bias that occurs when providers pressure or encourage clients to adopt contraception. Using cross-sectional data from reproductive-aged women in Burkina Faso, we describe lifetime prevalence of experiencing provider encouragement to use contraception due to provider perceptions of high parity (a type of upward provider bias) and provider discouragement from using contraception due to provider perceptions of low parity (a type of downward provider bias). We also examine associations between sociodemographic characteristics and experiences of provider encouragement to use contraception due to perceptions of high parity. Sixteen percent of participants reported that a provider had encouraged them to use contraception due to provider perceptions of high parity, and 1% of participants reported that a provider had discouraged them from using contraception because of provider perceptions of low parity. Being married, being from the rural site, having higher parity, and having attended the 45th-day postpartum check-up were associated with increased odds of being encouraged to use contraception due to provider perceptions of high parity. We find that experiences of upward provider bias linked to provider perceptions of high parity were considerably more common in this setting than downward provider bias linked to perceptions of low parity. Research into the mechanisms through which upward provider bias operates and how it may be mitigated is imperative to promote contraceptive autonomy.

Identifiants

pubmed: 37348946
pii: GHSP-D-22-00470
doi: 10.9745/GHSP-D-22-00470
pmc: PMC10285731
pii:
doi:

Substances chimiques

Contraceptive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NICHD NIH HHS
ID : P2C HD047873
Pays : United States
Organisme : NICHD NIH HHS
ID : P2C HD050924
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD049302
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD052468
Pays : United States

Informations de copyright

© Bullington et al.

Références

Stud Fam Plann. 1990 Mar-Apr;21(2):61-91
pubmed: 2191476
BMC Health Serv Res. 2017 Apr 12;17(1):268
pubmed: 28403858
Soc Sci Med. 2019 Oct;239:112531
pubmed: 31513932
SSM Qual Res Health. 2022 Dec;2:
pubmed: 37304900
BMC Health Serv Res. 2013 Dec 23;13:532
pubmed: 24365015
Stud Fam Plann. 2020 Jun;51(2):161-176
pubmed: 32358789
J Health Popul Nutr. 2006 Dec;24(4):489-97
pubmed: 17591346
Reprod Health. 2009 Feb 19;6:3
pubmed: 19228420
Glob Health Sci Pract. 2019 Jun 27;7(2):329-339
pubmed: 31249026
Int J Epidemiol. 2012 Jun;41(3):658-66
pubmed: 22685112
Stud Fam Plann. 2014 Mar;45(1):73-84
pubmed: 24615576
Stud Fam Plann. 1985 Sep-Oct;16(5):260-70
pubmed: 4060211
BMC Pregnancy Childbirth. 2018 May 16;18(1):172
pubmed: 29769052
BMJ Glob Health. 2021 Jun;6(6):
pubmed: 34162627
Contracept X. 2021 Mar 22;3:100063
pubmed: 33912827
Contraception. 2022 Nov;115:53-58
pubmed: 35779578
J Health Soc Behav. 2021 Jun;62(2):120-135
pubmed: 33843323
Glob Health Action. 2010 Sep 14;3:
pubmed: 20847837
Stud Fam Plann. 2021 Sep;52(3):299-320
pubmed: 34472623
Am J Prev Med. 2018 Nov;55(5):725-735
pubmed: 30342635
Expert Rev Pharmacoecon Outcomes Res. 2012 Apr;12(2):181-7
pubmed: 22458619
Glob Health Sci Pract. 2019 Sep 26;7(3):371-385
pubmed: 31515240
Glob Health Sci Pract. 2017 Mar 28;5(1):108-114
pubmed: 28126970
BMC Womens Health. 2020 Aug 12;20(1):170
pubmed: 32787924
Stud Fam Plann. 2023 Mar;54(1):201-230
pubmed: 36729070
Contraception. 2015 Aug;92(2):143-51
pubmed: 25869629
Lancet. 1992 Nov 28;340(8831):1334-5
pubmed: 1360046
Int Perspect Sex Reprod Health. 2014 Dec;40(4):176-83
pubmed: 25565345

Auteurs

Brooke W Bullington (BW)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. bbullington@unc.edu.
Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Nathalie Sawadogo (N)

Institut Supérieur des Sciences de la Population, Université Joseph Ki-ZERBO, Ouagadougo, Burkina Faso.

Katherine Tumlinson (K)

Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Department of Maternal Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Ana Langer (A)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.

Abdramane Soura (A)

Institut Supérieur des Sciences de la Population, Université Joseph Ki-ZERBO, Ouagadougo, Burkina Faso.

Pascal Zabre (P)

Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.

Ali Sié (A)

Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.

Leigh Senderowicz (L)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
Department of Gender and Women's Studies, University of Wisconsin-Madison, Madison, WI, USA.
Department of Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, WI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH